Pd01-03 third interim analysis (ia3) of the darolutamide observational (darol) study in patients with nonmetastatic castration-resistant prostate cancer (nmcrpc)
Journal of Urology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined